<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36883643</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2156</ISSN><JournalIssue CitedMedium="Internet"><Volume>146</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Brain : a journal of neurology</Title><ISOAbbreviation>Brain</ISOAbbreviation></Journal><ArticleTitle>Multiomics and machine-learning identify novel transcriptional and mutational signatures in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>3770</StartPage><EndPage>3782</EndPage><MedlinePgn>3770-3782</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/brain/awad075</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis is a fatal and incurable neurodegenerative disease that mainly affects the neurons of the motor system. Despite the increasing understanding of its genetic components, their biological meanings are still poorly understood. Indeed, it is still not clear to which extent the pathological features associated with amyotrophic lateral sclerosis are commonly shared by the different genes causally linked to this disorder. To address this point, we combined multiomics analysis covering the transcriptional, epigenetic and mutational aspects of heterogenous human induced pluripotent stem cell-derived C9orf72-, TARDBP-, SOD1- and FUS-mutant motor neurons as well as datasets from patients' biopsies. We identified a common signature, converging towards increased stress and synaptic abnormalities, which reflects a unifying transcriptional program in amyotrophic lateral sclerosis despite the specific profiles due to the underlying pathogenic gene. In addition, whole genome bisulphite sequencing linked the altered gene expression observed in mutant cells to their methylation profile, highlighting deep epigenetic alterations as part of the abnormal transcriptional signatures linked to amyotrophic lateral sclerosis. We then applied multi-layer deep machine-learning to integrate publicly available blood and spinal cord transcriptomes and found a statistically significant correlation between their top predictor gene sets, which were significantly enriched in toll-like receptor signalling. Notably, the overrepresentation of this biological term also correlated with the transcriptional signature identified in mutant human induced pluripotent stem cell-derived motor neurons, highlighting novel insights into amyotrophic lateral sclerosis marker genes in a tissue-independent manner. Finally, using whole genome sequencing in combination with deep learning, we generated the first mutational signature for amyotrophic lateral sclerosis and defined a specific genomic profile for this disease, which is significantly correlated to ageing signatures, hinting at age as a major player in amyotrophic lateral sclerosis. This work describes innovative methodological approaches for the identification of disease signatures through the combination of multiomics analysis and provides novel knowledge on the pathological convergencies defining amyotrophic lateral sclerosis.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Catanese</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8266-4913</Identifier><AffiliationInfo><Affiliation>Institute of Anatomy and Cell Biology, Ulm University School of Medicine, 89081 Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Protein Biochemistry, German Center for Neurodegenerative Diseases (DZNE), Ulm site, 89081 Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rajkumar</LastName><ForeName>Sandeep</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Anatomy and Cell Biology, Ulm University School of Medicine, 89081 Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sommer</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Anatomy and Cell Biology, Ulm University School of Medicine, 89081 Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masrori</LastName><ForeName>Pegah</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Laboratory of Neurobiology, Center for Brain &amp; Disease Research, VIB, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University Hospitals Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Experimental Neurology, Department of Neurosciences, Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hersmus</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Laboratory of Neurobiology, Center for Brain &amp; Disease Research, VIB, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University Hospitals Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Experimental Neurology, Department of Neurosciences, Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Damme</LastName><ForeName>Philip</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-4010-2357</Identifier><AffiliationInfo><Affiliation>Laboratory of Neurobiology, Center for Brain &amp; Disease Research, VIB, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University Hospitals Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Experimental Neurology, Department of Neurosciences, Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Witzel</LastName><ForeName>Simon</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-1841-954X</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Ulm University School of Medicine, 89081 Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ludolph</LastName><ForeName>Albert</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Translational Protein Biochemistry, German Center for Neurodegenerative Diseases (DZNE), Ulm site, 89081 Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Ulm University School of Medicine, 89081 Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Ritchie</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center for Neural Science and Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boeckers</LastName><ForeName>Tobias M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Institute of Anatomy and Cell Biology, Ulm University School of Medicine, 89081 Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Protein Biochemistry, German Center for Neurodegenerative Diseases (DZNE), Ulm site, 89081 Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mulaw</LastName><ForeName>Medhanie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Unit for Single-Cell Genomics, Medical Faculty, Ulm University, 89081 Ulm, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Brain</MedlineTA><NlmUniqueID>0372537</NlmUniqueID><ISSNLinking>0006-8950</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000095028" MajorTopicYN="N">Multiomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">deep learning</Keyword><Keyword MajorTopicYN="N">motor neurons</Keyword><Keyword MajorTopicYN="N">omics</Keyword></KeywordList><CoiStatement>P.V.D. reports to have served on advisory boards for Biogen, CSL Behring, Alexion Pharmaceuticals, Ferrer, QurAlis, Cytokinetics, Argenx, UCB, Muna Therapeutics, Alector, Augustine Therapeutics and VectorY (paid to institution). All the other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>8</Day><Hour>7</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36883643</ArticleId><ArticleId IdType="pmc">PMC10473564</ArticleId><ArticleId IdType="doi">10.1093/brain/awad075</ArticleId><ArticleId IdType="pii">7072405</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ryan M, Heverin M, McLaughlin RL, Hardiman O. Lifetime risk and heritability of amyotrophic lateral sclerosis. JAMA Neurol. 2019;76:1367&#x2013;1374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6646974</ArticleId><ArticleId IdType="pubmed">31329211</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Cooper-Knock J, Weimer AK, et al. . Genome-wide identification of the genetic basis of amyotrophic lateral sclerosis. Neuron. 2022;110:992&#x2013;1008.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9017397</ArticleId><ArticleId IdType="pubmed">35045337</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chi&#xf3; A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci. 2014;17:17&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Catanese A, Rajkumar S, Sommer D, et al. . Synaptic disruption and CREB-regulated transcription are restored by K+ channel blockers in ALS. EMBO Mol Med. 2021;13:e13131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8261490</ArticleId><ArticleId IdType="pubmed">34125498</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexandrov LB, Nik-Zainal S, Wedge DC, Campbell PJ, Stratton MR. Deciphering signatures of mutational processes operative in human cancer. Cell Rep. 2013;3:246&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3588146</ArticleId><ArticleId IdType="pubmed">23318258</ArticleId></ArticleIdList></Reference><Reference><Citation>Nik-Zainal S, Alexandrov LB, Wedge DC, et al. . Mutational processes molding the genomes of 21 breast cancers. Cell. 2012;149:979&#x2013;993.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3414841</ArticleId><ArticleId IdType="pubmed">22608084</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexandrov LB, Nik-Zainal S, Wedge DC, et al. . Signatures of mutational processes in human cancer. Nature. 2013;500:415&#x2013;421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3776390</ArticleId><ArticleId IdType="pubmed">23945592</ArticleId></ArticleIdList></Reference><Reference><Citation>Bustin SA, Benes V, Garson JA, et al. . The MIQE guidelines: Minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009;55:611&#x2013;622.</Citation><ArticleIdList><ArticleId IdType="pubmed">19246619</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D, Langmead B, Salzberg SL. HISAT: A fast spliced aligner with low memory requirements. Nat Methods. 2015;12:357&#x2013;360.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4655817</ArticleId><ArticleId IdType="pubmed">25751142</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D, Paggi JM, Park C, Bennett C, Salzberg SL. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol. 2019;37:907&#x2013;915.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7605509</ArticleId><ArticleId IdType="pubmed">31375807</ArticleId></ArticleIdList></Reference><Reference><Citation>Pertea M, Kim D, Pertea GM, Leek JT, Salzberg SL. Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown. Nat Protoc. 2016;11:1650&#x2013;1667.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5032908</ArticleId><ArticleId IdType="pubmed">27560171</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y, Smyth GK, Shi W. Featurecounts: An efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2013;30:923&#x2013;930.</Citation><ArticleIdList><ArticleId IdType="pubmed">24227677</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie ME, Phipson B, Wu D, et al. . Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4402510</ArticleId><ArticleId IdType="pubmed">25605792</ArticleId></ArticleIdList></Reference><Reference><Citation>Mootha VK, Lindgren CM, Eriksson KF, et al. . PGC-1&#x3b1;-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34:267&#x2013;273.</Citation><ArticleIdList><ArticleId IdType="pubmed">12808457</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Tamayo P, Mootha VK, et al. . Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545&#x2013;15550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1239896</ArticleId><ArticleId IdType="pubmed">16199517</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;ffler-Wirth H, Kalcher M, Binder H. oposSOM: R-package for high-dimensional portraying of genome-wide expression landscapes on Bioconductor. Bioinformatics. 2015;31:3225&#x2013;3227.</Citation><ArticleIdList><ArticleId IdType="pubmed">26063839</ArticleId></ArticleIdList></Reference><Reference><Citation>Merkel A, Fern&#xe1;ndez-Callejo M, Casals E, et al. . gemBS: High throughput processing for DNA methylation data from bisulfite sequencing. Bioinformatics. 2018;35:737&#x2013;742.</Citation><ArticleIdList><ArticleId IdType="pubmed">30137223</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinz S, Benner C, Spann N, et al. . Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell. 2010;38:576&#x2013;589.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2898526</ArticleId><ArticleId IdType="pubmed">20513432</ArticleId></ArticleIdList></Reference><Reference><Citation>Krzywinski M, Schein J, Birol I, et al. . Circos: An information aesthetic for comparative genomics. Genome Res. 2009;19:1639&#x2013;1645.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2752132</ArticleId><ArticleId IdType="pubmed">19541911</ArticleId></ArticleIdList></Reference><Reference><Citation>Baxi EG, Thompson T, Li J, et al. . Answer ALS, a large-scale resource for sporadic and familial ALS combining clinical and multi-omics data from induced pluripotent cell lines. Nat Neurosci. 2022;25:226&#x2013;237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8825283</ArticleId><ArticleId IdType="pubmed">35115730</ArticleId></ArticleIdList></Reference><Reference><Citation>Gehring JS, Fischer B, Lawrence M, Huber W. Somaticsignatures: Inferring mutational signatures from single-nucleotide variants. Bioinformatics. 2015;31:3673&#x2013;3675.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4817139</ArticleId><ArticleId IdType="pubmed">26163694</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexandrov LB, Stratton MR. Mutational signatures: The patterns of somatic mutations hidden in cancer genomes. Curr Opin Genet Dev. 2014;24:52&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3990474</ArticleId><ArticleId IdType="pubmed">24657537</ArticleId></ArticleIdList></Reference><Reference><Citation>Abadi M, Agarwal A, Barham P, et al. . TensorFlow: Large-scale machine learning on heterogeneous systems. Preprint at arXiv. 2015;1603.04467.</Citation></Reference><Reference><Citation>Japtok J, Lojewski X, Naumann M, et al. . Stepwise acquirement of hallmark neuropathology in FUS-ALS iPSC models depends on mutation type and neuronal aging. Neurobiol Dis. 2015;82:420&#x2013;429.</Citation><ArticleIdList><ArticleId IdType="pubmed">26253605</ArticleId></ArticleIdList></Reference><Reference><Citation>Higelin J, Demestre M, Putz S, et al. . FUS mislocalization and vulnerability to DNA damage in ALS patients derived hiPSCs and aging motoneurons. Front Cell Neurosci. 2016;10:290.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5183648</ArticleId><ArticleId IdType="pubmed">28082870</ArticleId></ArticleIdList></Reference><Reference><Citation>Catanese A, Olde Heuvel F, Mulaw M, et al. . Retinoic acid worsens ATG10-dependent autophagy impairment in TBK1-mutant hiPSC-derived motoneurons through SQSTM1/p62 accumulation. Autophagy. 2019;15:1719&#x2013;1737.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6735587</ArticleId><ArticleId IdType="pubmed">30939964</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimori K, Ishikawa M, Otomo A, et al. . Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent. Nat Med. 2018;24:1579&#x2013;1589.</Citation><ArticleIdList><ArticleId IdType="pubmed">30127392</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall CE, Yao Z, Choi M, et al. . Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS. Cell Rep. 2017;19:1739&#x2013;1749.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5464993</ArticleId><ArticleId IdType="pubmed">28564594</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Lin S, Staats KA, et al. . Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat Med. 2018;4:313&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6112156</ArticleId><ArticleId IdType="pubmed">29400714</ArticleId></ArticleIdList></Reference><Reference><Citation>Sareen D, O'Rourke JG, Meera P, et al. . Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci Transl Med. 2013;5:208ra149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4090945</ArticleId><ArticleId IdType="pubmed">24154603</ArticleId></ArticleIdList></Reference><Reference><Citation>Henstridge CM, Sideris DI, Carroll E, et al. . Synapse loss in the prefrontal cortex is associated with cognitive decline in amyotrophic lateral sclerosis. Acta Neuropathol. 2018;135:213&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5773656</ArticleId><ArticleId IdType="pubmed">29273900</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer CS, Cohen RN, Sironi F, et al. . An interaction between synapsin and C9orf72 regulates excitatory synapses and is impaired in ALS/FTD. Acta Neuropathol. 2022;144:437&#x2013;464.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9381633</ArticleId><ArticleId IdType="pubmed">35876881</ArticleId></ArticleIdList></Reference><Reference><Citation>Upadhyay G. Emerging role of lymphocyte antigen-6 family of genes in cancer and immune cells. Front Immunol. 2019;10:819.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6491625</ArticleId><ArticleId IdType="pubmed">31068932</ArticleId></ArticleIdList></Reference><Reference><Citation>Miwa JM, Anderson KR, Hoffman KM. Lynx prototoxins: Roles of endogenous mammalian neurotoxin-like proteins in modulating nicotinic acetylcholine receptor function to influence complex biological processes. Front Pharmacol. 2019;10:343.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6502960</ArticleId><ArticleId IdType="pubmed">31114495</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen W, Diekstra FP, Harschnitz O, et al. . Whole blood transcriptome analysis in amyotrophic lateral sclerosis: A biomarker study. PLoS ONE. 2018;3:e0198874.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6016933</ArticleId><ArticleId IdType="pubmed">29939990</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphrey J, Venkatesh S, Hasan R, et al. . Integrative transcriptomic analysis of the amyotrophic lateral sclerosis spinal cord implicates glial activation and suggests new risk genes. Nat Neurosci. 2023;26:150&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pubmed">36482247</ArticleId></ArticleIdList></Reference><Reference><Citation>Koopmans F, van Nierop P, Andres-Alonso M, et al. . SynGO: An evidence-based, expert-curated knowledge base for the synapse. Neuron. 2019;103:217&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6764089</ArticleId><ArticleId IdType="pubmed">31171447</ArticleId></ArticleIdList></Reference><Reference><Citation>Staats KA, Borchelt DR, Tansey MG, Wymer J. Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis. Mol Neurodegener. 2022;17:11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8785449</ArticleId><ArticleId IdType="pubmed">35073950</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller T, Cudkowicz M, Shaw PJ, et al. . Phase 1-2 trial of antisense oligonucleotide Tofersen for SOD1 ALS. N Engl J Med. 2020;383:109&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pubmed">32640130</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran H, Moazami MP, Yang H, et al. . Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotide. Nat Med. 2022;28:117&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8861976</ArticleId><ArticleId IdType="pubmed">34949835</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardar R, Sharma A, Gupta D. Machine learning assisted prediction of prognostic biomarkers associated with COVID-19, using clinical and proteomics data. Front Genet. 2021;12:636441.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8175075</ArticleId><ArticleId IdType="pubmed">34093642</ArticleId></ArticleIdList></Reference><Reference><Citation>Huseby CJ, Delvaux E, Brokaw DL, et al. . Blood RNA transcripts reveal similar and differential alterations in fundamental cellular processes in Alzheimer's disease and other neurodegenerative diseases. Alzheimers Dement. Published online 21 December 2022. doi:10.1002/alz.12880</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12880</ArticleId><ArticleId IdType="pubmed">36541444</ArticleId></ArticleIdList></Reference><Reference><Citation>Eckardt JN, Middeke JM, Riechert S, et al. . Deep learning detects acute myeloid leukemia and predicts NPM1 mutation status from bone marrow smears. Leukemia. 2022;36:111&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727290</ArticleId><ArticleId IdType="pubmed">34497326</ArticleId></ArticleIdList></Reference><Reference><Citation>Namboori SC, Thomas P, Ames R, et al. . Single-cell transcriptomics identifies master regulators of neurodegeneration in SOD1 ALS iPSC-derived motor neurons. Stem Cell Rep. 2021;16:3020&#x2013;3035.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8693652</ArticleId><ArticleId IdType="pubmed">34767750</ArticleId></ArticleIdList></Reference><Reference><Citation>Dash BP, Freischmidt A, Weishaupt JH, et al. . Downstream effects of mutations in SOD1 and TARDBP converge on gene expression impairment in patient-derived motor neurons. Int J Mol Sci. 2022;23:9652.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9456253</ArticleId><ArticleId IdType="pubmed">36077049</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith AST, Chun C, Hesson J, et al. . Human induced pluripotent stem cell-derived TDP-43 mutant neurons exhibit consistent functional phenotypes across multiple gene edited lines despite transcriptomic and splicing discrepancies. Front Cell Dev Biol. 2021;9:728707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8511491</ArticleId><ArticleId IdType="pubmed">34660586</ArticleId></ArticleIdList></Reference><Reference><Citation>Workman MJ, Lim RG, Wu J, et al. . Large-scale differentiation of iPSC-derived motor neurons from ALS and control subjects. Neuron. Published online 2 February 2023. doi:10.1016/j.neuron.2023.01.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2023.01.010</ArticleId><ArticleId IdType="pubmed">36764301</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H, Lee JJ, Park NY, et al. . Multi-omic analysis of selectively vulnerable motor neuron subtypes implicates altered lipid metabolism in ALS. Nat Neurosci. 2021;24:1673&#x2013;1685.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8639773</ArticleId><ArticleId IdType="pubmed">34782793</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho R, Workman MJ, Mathkar P, et al. . Cross-comparison of human iPSC motor neuron models of familial and sporadic ALS reveals early and convergent transcriptomic disease signatures. Cell Syst. 2021;12:159&#x2013;175.e9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7897311</ArticleId><ArticleId IdType="pubmed">33382996</ArticleId></ArticleIdList></Reference><Reference><Citation>Devlin AC, Burr K, Borooah S, et al. . Human iPSC-derived motoneurons harbouring TARDBP or C9ORF72 ALS mutations are dysfunctional despite maintaining viability. Nat Commun. 2015;6:5999.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4338554</ArticleId><ArticleId IdType="pubmed">25580746</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena S, Roselli F, Singh K, et al. . Neuroprotection through excitability and mTOR required in ALS motoneurons to delay disease and extend survival. Neuron. 2013;80:80&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">24094105</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JY, Lee JD, Phipps S, et al. . Absence of toll-like receptor 4 (TLR4) extends survival in the hSOD1 G93A mouse model of amyotrophic lateral sclerosis. J Neuroinflammation. 2015;12:90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4431460</ArticleId><ArticleId IdType="pubmed">25962427</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Spek RAA, van Rheenen W, Pulit SL, et al. . The project MinE databrowser: Bringing large-scale whole-genome sequencing in ALS to researchers and the public. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:432&#x2013;440.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7893599</ArticleId><ArticleId IdType="pubmed">31280677</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou Y, Dan X, Babbar M, et al. . Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol. 2019;15:565&#x2013;581.</Citation><ArticleIdList><ArticleId IdType="pubmed">31501588</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdez G, Tapia JC, Lichtman JW, et al. . Shared resistance to ageing and ALS in neuromuscular junctions of specific muscles. PLoS ONE. 2012;7:e34640.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3317643</ArticleId><ArticleId IdType="pubmed">22485182</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>